Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




LAMP Assay Developed for Threadworms in Stool and Urine

By LabMedica International staff writers
Posted on 26 Jul 2016
Strongyloides stercoralis, commonly known as threadworm, is a nematode globally distributed but mainly endemic in tropical and subtropical regions and is the chief causative agent of human strongyloidiasis.

The diagnosis of strongyloidiasis is suspected when clinical signs and symptoms, eosinophilia or serologic findings are observed, but definitive diagnosis is accomplished by parasitological examination of stool samples allowing the morphological identification of S. More...
stercoralis, including direct smear in saline, the spontaneous sedimentation method, and centrifugation.

Scientists at the University of Salamanca (Salamanca, Spain) and their colleagues developed, a molecular assay using loop mediated isothermal amplification (LAMP) methodology as a simple, sensible and robust method for the detection of S. venezuelensis DNA in a well-established rodent model infection in both stool and urine samples. The LAMP assay was also successfully evaluated in patients´ stool samples. The LAMP assay (Strong-LAMP) is a useful molecular tool in a strongyloidiasis infection model and could be a potential field-friendly diagnostic test in a clinical setting, following further validation.

Stool samples were collected from 12 patients who showed significant levels of immunoglobulin E (IgE), eosinophilia or other symptoms suggestive of disease. Stool samples were examined after arrival by qualified laboratory technicians. Eleven of these 12 stool samples were subjected to different parasitological methods as screening tests for strongyloidiasis, including microscopic examination (MOE) for the presence of rabditiform larvae in direct fecal smears, agar plate culture (APC) or Harada-Mori´s filter paper culture method (HMM).

DNA was extracted from the human stool samples and tested by an optimized real-time polymerase chain reaction. To evaluate the ability of the LAMP assay designed to amplify S. venezuelensis DNA in real samples, the team used DNA extracted from the pooled feces and urine samples taken daily from each experimentally infected group of rats with different doses. To check whether LAMP assay designed was also able to amplify DNA from S. stercoralis in clinical samples, they used the patients´ stool samples included in the study.

All patients´ stool samples were tested by RT-PCR and LAMP to compare results. The RT-PCR resulted positive in 6/7 patients´ stool samples with confirmed strongyloidiasis by parasitological tests previously applied. In addition, a positive result was obtained in a sample to which no parasitological test could be performed; negative results were obtained in negative parasitological samples for S. stercoralis. All patients´ stool samples with confirmed strongyloidiasis by parasitological tests could be detected by LAMP, including the sample, which resulted negative in previous RT-PCR analyses.

The authors concluded that the Strong-LAMP assay can be applied effectively for the detection of S. stercoralis DNA in patients´ stool samples. The successfully amplification of Strongyloides spp. DNA in infected urine samples by LAMP assay as well as the advantages that urine would have in collection, storage and processing in comparison to patients´ stool samples, should make us consider the possibility of starting to use urine specimens in diagnosing human strongyloidiasis. The study was published on July 14, 2016, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
University of Salamanca



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Automated Immunoassay Analyzer
SuperFlex™
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.